Portfolio company
Tesorai
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Tesorai develops an artificial intelligence platform for mass spectrometry proteomics analysis serving biotechnology and pharmaceutical research teams.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Atometra
Atometra automates chemical analysis through mass spectrometry to assist pharmaceutical companies with drug discovery and development processes.
Proteomics
This company develops automated benchtop instruments for multiplexed protein analysis to assist researchers in the biotechnology and pharmaceutical industries.
ProtOS
This company develops artificial intelligence models to design de-novo proteins for the degradation of undruggable targets for the pharmaceutical and medical biotechnology industries.
Open Protein
This company provides a no-code machine learning platform for protein engineering and sequence generation to researchers in biotechnology, pharmaceuticals and academia.
TANDEMAI
This company provides a platform combining artificial intelligence and physics-based computation with wet lab services for biotech and pharmaceutical drug discovery.
DeepSeq.AI
DeepSeq.AI develops an artificial intelligence platform for protein drug discovery and biologics design for pharmaceutical and biotechnology companies.
Terray
This company develops a generative artificial intelligence and high-throughput experimentation platform for pharmaceutical and biotechnology organisations to accelerate small molecule drug discovery.
Tessel Biosciences
The company develops artificial intelligence models and patient-derived virtual tissues to accelerate drug discovery for pharmaceutical and biotechnology organisations.
